JoanRoseTymon-RosarioMD

PubMed

• Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2024 Apr 1
• 4 citations
  Advances in antibody-drug conjugates for gynecologic malignancies.
  Joan Tymon-Rosario, Megan Gorman, Debra L Richardson, Christina Washington, Alessandro D Santin> ;Current Opinion in Obstetrics & Gynecology. 2023 Feb 1
• What role does adjuvant therapy play in the management of endometrial cancer?
  Gloria Shining Huang, Joan Tymon-Rosario, Alessandro D Santin> ;Expert Opinion on Pharmacotherapy. 2023 Jan 1
• 2 citations
  Targeted Therapies in the Treatment of Uterine Serous Carcinoma.
  Joan R Tymon-Rosario, Megan Gorman, Alessandro D Santin> ;Current Treatment Options in Oncology. 2022 Dec 1
• 6 citations
  Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
  Manavella, D., Ghanshyam Yadav, Dana M Roque, Stefania Bellone, Diego D Manavella, Tobias M P Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent M...> ;Gynecologic Oncology. 2022 Aug 1
• 2 citations
  Minimally Invasive Ovarian-Preserving Approach for the Management of a Sclerosing Stromal Tumor in an Adolescent: A Case Report.
  Chaarushi Ahuja, Joan Tymon-Rosario, Douglas Rottmann, Rita Abi Raad, Dan-Arin Silasi, Alla Vash-Margita> ;Journal of Pediatric and Adolescent Gynecology. 2022 Aug 1
• 12 citations
  Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine dip...
  Manavella, D., Joan R Tymon-Rosario, Paola Manara, Diego D Manavella, Stefania Bellone, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipp...> ;Gynecologic Oncology. 2022 Jul 1
• 3 citations
  Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2022 Jun 1
• 8 citations
  Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer.
  Levent Mutlu, Joan Tymon-Rosario, Justin Harold, Gulden Menderes> ;Expert Review of Anticancer Therapy. 2022 Jun 1
• Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus.
  Justin Harold, Joan Tymon-Rosario, Gulden Menderes, Murphy, C.> ;Gynecologic Oncology Reports. 2022 Apr 1
• 28 citations
  A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
  Stefania Bellone, Dana M Roque, Eric R Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan...> ;Cancer. 2022 Mar 15
• 7 citations
  Immune checkpoint inhibitors for recurrent endometrial cancer.
  Levent Mutlu, Justin Harold, Joan Tymon-Rosario, Alessandro D Santin> ;Expert Review of Anticancer Therapy. 2022 Mar 1
• 3 citations
  An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva.
  Jessie Y Li, Christopher K Arkfeld, Joan Tymon-Rosario, Emily Webster, Peter Schwartz, Shari Damast, Gulden Menderes> ;Journal of Gynecologic Oncology. 2022 Mar 1
• 1 citations
  Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.
  Jessie Y Li, Levent Mutlu, Joan Tymon-Rosario, Wafa Khadraoui, Nupur Nagarkatti, Pei Hui, Natalia Buza, Lingeng Lu, Peter Schwartz, Gulden Menderes> ;Gynecologic Oncology Reports. 2022 Feb 1
• 10 citations
  Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.
  Joan Tymon-Rosario, Naomi N Adjei, Dana M Roque, Alessandro D Santin> ;Cancers. 2021 Dec 12
• 8 citations
  DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
  Joan Tymon-Rosario, Elena Bonazzoli, Stefania Bellone, Aranzazu Manzano, Silvia Pelligra, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Burak Zeybek, Paola Manara...> ;Gynecologic Oncology. 2021 Nov 1
• 12 citations
  Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
  Joan Tymon-Rosario, Eric R. Siegel, Stefania Bellone, Justin Harold, Naomi N Adjei, Burak Zeybek, Dennis Mauricio, Gary Altwerger, Gulden Menderes, Elena Ratner, Mitch...> ;Gynecologic Oncology. 2021 Oct 1
• 8 citations
  Financial toxicity in patients with gynecologic malignancies: a cross sectional study
  Burak Zeybek, Emily Webster, Natalia Pogosian, Joan Tymon-Rosario, Alan Balch, Gary Altwerger, Mitchell Clark, Gulden Menderes, Gloria S. Huang, Masoud Azodi, Elena Ra...> ;Journal of Gynecologic Oncology. 2021 Jul 23
• 26 citations
  A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated charact...
  Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jung-Soo Lee, ...> ;Annals of Oncology. 2021 Apr 28
• 4 citations
  Variability in the identification of lymphovascular space invasion for early stage cervical cancer.
  Vaagn Andikyan, Margaret Griffith, Joan Tymon-Rosario, Mazdak Momeni, Nebras Zeizafoun, Ippolito Modica, Ninad M Patil, Peter Dottino, K. Zakashansky, Tamara Kalir> ;Surgical Oncology. 2021 Sep 1
• 28 citations
  Immunotherapy in Cervical Cancer.
  Dennis Mauricio, Burak Zeybek, Joan Tymon-Rosario, Justin Harold, Alessandro D. Santin> ;Current Oncology Reports. 2021 Apr 14
• 46 citations
  Integrated mutational landscape analysis of uterine leiomyosarcomas
  Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara G...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Apr 13
• 4 citations
  Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.
  Jessie Y. Li, Johanna D'Addario, Joan Tymon-Rosario, Gulden Menderes, Melissa R. Young, Kimberly L. Johung, Elena Ratner, Mary Jane Minkin, Shari Damast> ;American Journal of Clinical Oncology. 2021 Apr 1
• Robotic Low Anterior Resection and Partial Bladder Resection for Management of Locoregional Endometrial Cancer Recurrence.
  Wafa Khadraoui, Joan Tymon-Rosario, Nupur Nagarkatti, Gulden Menderes> ;Journal of Minimally Invasive Gynecology. 2021 Feb 1
• Novel antibody-drug conjugates: current and future roles in gynecologic oncology.
  Joan Tymon-Rosario, Burak Zeybek, Alessandro D. Santin> ;Current Opinion in Obstetrics & Gynecology. 2021 Feb 1
• Join now to see all